Matinas BioPharma Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Matinas BioPharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Matinas BioPharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.62M, a 18.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.62M -$588K -18.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.77M -$575K -17.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.92M -$561K -16.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.06M -$549K -15.2% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $3.21M -$536K -14.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.35M -$599K -15.2% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $3.48M -$603K -14.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $3.61M -$606K -14.4% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $3.74M -$611K -14% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $3.94M +$910K +30% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $4.08M +$933K +29.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $4.22M +$942K +28.8% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $4.35M +$951K +28% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $3.03M -$489K -13.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $3.15M -$494K -13.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.28M -$485K -12.9% Dec 31, 2020 10-K/A 2022-03-11
Q3 2020 $3.4M -$476K -12.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $3.52M -$468K -11.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.64M -$460K -11.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.76M Dec 31, 2019 10-K 2021-03-29
Q3 2019 $3.88M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $3.99M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $4.1M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.